Opticyte inc
WebOpticyte has raised a total of $5.7M in funding over 3 rounds. Their latest funding was raised on Nov 1, 2024 from a Seed round. Opticyte is funded by 4 investors. SWAN Venture Fund and StarFish Medical are the most recent investors. Funding Rounds Number of Funding Rounds 3 Total Funding Amount $5.7M WebOpticyte is a medical device start-up that was founded to address one of healthcare’s most compelling unmet needs, the early detection and treatment of organ failure and sepsis.
Opticyte inc
Did you know?
WebOpticyte is committed to protecting the integrity and objectivity of its research activities by ensuring that the design, conduct, and reporting of research will not be biased or appear to be biased by a personal financial conflict of interest.
WebJan 13, 2024 · SEATTLE, Washington, January 12, 2024 – Opticyte, Inc, a medical device innovator developing proprietary advanced algorithms and tailored optical spectroscopy technology to measure and detect low oxygen levels in cells to prevent organ failure, announced the recent culmination of private capital and grant funding. WebJan 12, 2024 · Opticyte, Inc, a medical device innovator developing proprietary advanced algorithms and tailored optical spectroscopy technology to measure and detect low …
WebSEATTLE--(BUSINESS WIRE)--Opticyte, Inc, a medical device innovator developing proprietary advanced algorithms and tailored optical spectroscopy technology to measure … WebAnn Arbor, Michigan, United States3K followers 500+ connections. Join to view profile. FlexDex Surgical. Case Western Reserve University School of Medicine. UM MIC.
WebSerum Tears Made Simple. At Vital Tears, our mission is to make serum tears easily available and affordable for every patient. We've done that for over 10,000 people since …
WebRecognized by the FDA as a Breakthrough Device, the Opticyte Cell O₂ Monitor is the first device to measure oxygen levels inside cells in real time. Organ failure results from … The Opticyte Cell O₂ Monitor shines light in the visible and near-infrared spectrum … Opticyte’s Cell O₂ Monitor holds the promise to reduce organ failure and death … Opticyte has been capital-efficient and is funded for the next year with a non … Opticyte Earns FDA Breakthrough Device Designation for the First Cell O 2 Patient … Opticyte is a medical device company dedicated to developing the first and only … lab at 1805 california st. stockton caWebDec 11, 2024 · Opticyte’s Cell O 2 Monitor holds the promise of reducing organ failure and death associated with sepsis. It’s a worthwhile endeavor, given that millions of people suffer the effects of organ failure each year. The mystery lies in … project64 failed to change display modeWebJan 12, 2024 · Opticyte received $1.1MM of initial non-dilutive funding from the NIH in 2016, with the most recent $2.9MM SBIR Phase IIB grant awarded in May of 2024. Follow Opticyte on Twitter and LinkedIn for the latest news and information. ABOUT OPTICYTE: Opticyte, Inc, founded in 2016, is a spinoff from the University of Washington. Headquartered in ... project\u0027s mirr with a reinvestment rate of 10WebOpticyte Secures $4.6 Million in Funding to Develop First Cell O2 Monitor for Reducing Organ Failure SEATTLE--(BUSINESS WIRE)--Opticyte, Inc, a medical device innovator developing proprietary advanced algorithms and tailored optical spectroscopy technology to measure and detect low oxygen levels in cells to prevent organ failure, announced the recent … lab at advent healthWebJan 11, 2024 · Opticyte will be testing the device with emergency patients at Seattle’s Harborview Medical Center. The observational study is scheduled to launch in May or … project: the perceiveWebMar 24, 2024 · RESEARCH TRIANGLE PARK, N.C., March 24, 2024 (GLOBE NEWSWIRE) -- Opticyte® Amniotic Ocular Matrix, a product of Research Triangle Park-based Merakris Therapeutics, has gotten the attention of a ... lab at bathurst and lawrenceWebJan 11, 2024 · (Opticyte Photo) University of Washington biotech spinout Opticyte has landed $2.9 million in federal grants and $1.7 million in seed funding. The Seattle startup is developing a non-invasive... lab at boxgrove